Sector Gamma As as of Dec. 31, 2016
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 26 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 9.2 | $49M | 667k | 73.55 | |
| Baxter International (BAX) | 8.0 | $42M | 953k | 44.34 | |
| Abbott Laboratories (ABT) | 7.1 | $38M | 977k | 38.41 | |
| PerkinElmer (RVTY) | 6.1 | $33M | 623k | 52.15 | |
| Ironwood Pharmaceuticals (IRWD) | 5.7 | $30M | 2.0M | 15.29 | |
| Boston Scientific Corporation (BSX) | 5.1 | $27M | 1.3M | 21.63 | |
| Bristol Myers Squibb (BMY) | 4.9 | $26M | 449k | 58.44 | |
| Gilead Sciences (GILD) | 4.8 | $26M | 359k | 71.61 | |
| Shire | 4.7 | $25M | 147k | 170.38 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.6 | $25M | 334k | 73.67 | |
| Integra LifeSciences Holdings (IART) | 4.5 | $24M | 281k | 85.79 | |
| Masimo Corporation (MASI) | 4.0 | $21M | 313k | 67.40 | |
| Bio-Rad Laboratories (BIO) | 3.9 | $21M | 114k | 182.28 | |
| Anthem (ELV) | 3.8 | $20M | 141k | 143.77 | |
| Merck & Co (MRK) | 3.1 | $17M | 283k | 58.87 | |
| McKesson Corporation (MCK) | 3.0 | $16M | 115k | 140.45 | |
| Patterson Companies (PDCO) | 3.0 | $16M | 386k | 41.03 | |
| Momenta Pharmaceuticals | 2.4 | $13M | 855k | 15.05 | |
| CIGNA Corporation | 2.4 | $13M | 95k | 133.39 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $9.8M | 68k | 143.44 | |
| LifePoint Hospitals | 1.8 | $9.4M | 165k | 56.80 | |
| Exelixis (EXEL) | 1.5 | $7.8M | 520k | 14.91 | |
| Owens & Minor (OMI) | 1.4 | $7.6M | 214k | 35.29 | |
| Impax Laboratories | 1.2 | $6.6M | 499k | 13.25 | |
| Alexion Pharmaceuticals | 1.1 | $5.9M | 49k | 122.35 | |
| Tenet Healthcare Corporation (THC) | 0.7 | $3.7M | 252k | 14.84 |
